VRTX

Vertex Pharmaceuticals Incorporated (VRTX) Investor Questions

Review Vertex Pharmaceuticals Incorporated (VRTX) faq with server-rendered company data, supporting context and links to related investor research.

Company
Vertex Pharmaceuticals Incorporated
Sector
Healthcare
Industry
Biotechnology
Overall BTI score
72
Annual revenue
$12.00B
Annual net income
$3.95B
Annual free cash flow
$3.19B

Vertex Pharmaceuticals Incorporated (VRTX) Investor Questions research

Vertex Pharmaceuticals Incorporated trades under the ticker VRTX. The company is classified in the Healthcare sector and the Biotechnology industry.

Investors commonly review VRTX through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. The linked research sections provide a separate crawlable page for each data-rich topic.